The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review

Fan Chao1, Shiyu Wang1, Cong Zhang1

  • 1Department of Urology, Jinshan Hospital, Fudan University, Shanghai, China.

Insights

Circular RNAs (circRNAs) play a crucial role in prostate cancer progression, influencing tumor growth, metastasis, and drug resistance. Understanding these circRNAs offers potential for novel prostate cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer remains a significant health concern for men globally.
  • Aberrant expression of circular RNAs (circRNAs) is observed in various cancers, including prostate cancer.
  • CircRNAs are implicated in critical cancer hallmarks such as metastasis, proliferation, and drug resistance.

Approach:

  • A systematic literature review was conducted using PubMed and Web of Science databases.
  • Searched for publications on circRNAs and prostate cancer up to June 16, 2021.
  • Included 73 publications to summarize the biological roles of circRNAs in prostate cancer.

Key Points:

  • Dysregulated circRNAs impact prostate cancer cell cycle, proliferation, migration, invasion, and metastasis.
  • CircRNAs are involved in drug resistance and radiosensitivity in prostate cancer.
  • CircRNAs can function via extracellular vesicles (EVs) and serve as diagnostic and prognostic biomarkers.

Conclusions:

  • CircRNAs are implicated in the tumorigenesis and progression of prostate cancer.
  • Understanding circRNA mechanisms may lead to the development of new therapeutic strategies for prostate cancer.
  • Specific circRNAs correlate with clinicopathological features, highlighting their potential clinical relevance.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.5K